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Abstract
Versican/PG-M (proteoglycan-mesenchymal) is a large chondroitin sulfate (CS) proteoglycan of the extracellular matrix
(ECM) that is constitutively expressed in adult tissues such as dermis and blood vessels. It serves as a structural
macromolecule of the ECM, while in embryonic tissue it is transiently expressed at high levels and regulates cell adhesion,
migration, proliferation, and differentiation. Knock-in mouse embryonic (Cspg2
D3/D3) fibroblasts whose versican lack the A
subdomain of the G1 domain exhibit low proliferation rates and acquire senescence. It was suspected that chondroitin
sulfate on versican core protein would be altered when the A subdomain was disrupted, so fibroblasts were made from
homozygous Cspg2
D3/D3 mouse embryos to investigate the hypothesis. Analysis of the resulting versican deposition
demonstrated that the total versican deposited in the Cspg2
D3/D3 fibroblasts culture was approximately 50% of that of the
wild type (WT), while the versican deposited in the ECM of Cspg2
D3/D3 fibroblasts culture was 35% of that of the WT,
demonstrating the lower capacity of mutant (Cspg2
D3/D3) versican deposited in the ECM. The analysis of CS expression in
the Cspg2
D3/D3 fibroblasts culture compared with wild-type fibroblasts showed that the composition of the non-sulfate
chondroitin sulfate isomer on the versican core protein increased in the cell layer but decreased in the culture medium.
Interestingly, chondroitin sulfate E isomer was found in the culture medium. The amount of CS in the Cspg2
D3/D3 cell layer
of fibroblasts with mutant versican was dramatically decreased, contrasted to the amount in the culture medium, which
increased. It was concluded that the disruption of the A subdomain of the versican molecule leads to lowering of the amount
of versican deposited in the ECM and the alteration of the composition and content of CS on the versican molecule.
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Introduction
Versican/PG-M is a large chondroitin sulfate (CS)
proteoglycan of the extracellular matrix (ECM),
mainly synthesized by fibroblasts and vascular
smooth muscle cells. Its core protein consists of
two globular domains G1 and G3 at the N- and
C-termini, respectively, and two CS attachment
domains, CSa and CSb, between the two globular
domains. As many as 23 CS chains can be attached
to these domains, causing the molecular mass of
versican to reach up to 1,000 kDa. The N-terminal
G1 domain consists of A, B, B? looped subdomains.
The B-B? stretch binds hyaluronan, and the A
subdomain enhances the binding (1). The
C-terminal G3 domain binds other ECM mole-
cules, including fibrillins (2), fibulin-1,2 (3,4),
tenascin (5 7), type I collagen, and fibronectin
(8). By interacting with these molecules, versican
is incorporated into the ECM and serves as a
structural macromolecule.
Versican exhibits two distinct expression patterns.
In adult tissues it is constitutively expressed in
epithelial and connective tissues and serves as a
structural macromolecule of the ECM, while in
Correspondence: Prachya Kongtawelert, Thailand Excellence Center for Tissue Engineering, Department of Biochemistry, Faculty of Medicine, Chiang Mai
University, Chiang Mai, 50000 Thailand. Fax:  66-53-217144. E-mail: pkongtaw@mail.med.cmu.ac.th
(Received 1 November 2008; accepted 13 January 2009)
Upsala Journal of Medical Sciences. 2009; 114: 73 81
ISSN 0300-9734 print/ISSN 1502-4725 online # 2009 Informa UK Ltd. (Informa Healthcare, Taylor & Francis AS)
DOI: 10.1080/03009730902761722embryonic tissue it is transiently expressed at high
levels and regulates cell behavior such as adhesion
(9 11), migration (12 14), proliferation (15 17),
and differentiation (18,19). The G3 domain of
versican has been shown to enhance the proliferation
of NIH3T3 fibroblasts through an epidermal growth
factor (EGF)-like motif (20). The G3 domain with-
out the EGF-like motif enhances the interaction of
EGF receptor (EGFR) and b1-integrin, impairing
the growth of U87 astrocytoma cells (21). The V1
variant enhances proliferation and inhibits the apop-
tosis of NIH3T3 fibroblasts, while the V2 variant
does the opposite (17). Chondroitin sulfate chains
on the versican molecule bind to several biological
molecules such as chemokines, CD44, and selectins.
Serreno et al. reported that the short V3 isoform of
versican that lacks CS chains could reverse the
malignant phenotype of melanoma cells (22).
Recently, we generated knock-in mice
(Cspg2
D3/D3) whose versican lacks the A subdomain
of the G1 domain. These mice, expressing the
mutant versican at a level of  50% (compared
with normal versican in wild-type mice), exhibit
abnormalities in cardiovascular systems and skin,
contrasting to versican-null hdf mice which die at
E9.5 from severe cardiac defects (23). As hdf
heterozygotes expressing  50% normal versican
are viable with no obvious phenotype, the abnorm-
alities of embryos are likely due to decreased levels of
versican deposition in the ECM by the absence of
the A subdomain.
Embryonic fibroblasts obtained from Cspg2
D3/D3
mice exhibited unusual characteristics. Within 20
passages, the rate of proliferation of the Cspg2
D3/D3
fibroblastsslowed,andthecellsexhibitedsenescence.
Whereas the extracellular matrix of the wild-type
fibroblasts exhibited a network structure of hyalur-
onan and versican, that of the Cspg2
D3/D3 fibroblasts
exhibited 30% and 85% deposition of versican
and hyaluronan (HA) without such a structure. In
this experiment we examined the chondroitin sulfate
composition in proteoglycan molecules from
Cspg2
D3/D3 fibroblasts culture comparing them with
wild-type (WT) fibroblasts culture.
Materials and methods
WTand the Cspg2
D3/D3 mouse embryonic fibroblast
culture preparation
Female Cspg2
WT/D3 and male Cspg2
WT/D3 mice were
mated and allowed to gestate. These mice produced
WT heterozygous (Cspg2
WT/D3) and homozygous
(Cspg2
D3/D3) offspring whose versican lacked the A
subdomain. After 12 days, the pregnant mice were
killed using carbon dioxide gas. The placentas were
removed, and each embryo was separated and
placed in a Petri dish containing 1% penicillin/
streptomycin phosphate buffer saline (PBS) solu-
tion. Each embryo’s tail was cut and collected in a
microcentrifuge tube for further genotyping. The
rest of the embryo was roughly cut into small pieces
using scissors. Trypsin/EDTA was added to those
pieces, and then incubated for 15 30 minutes.
Dulbecco’s modified Eagle’s medium (DMEM)
containing 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin was added to stop the reac-
tion. The medium was removed by suction, and the
remaining tissue was passed through a cell strainer to
get single cells. Medium was then added, and the
cells were cultured until they reached confluence. At
the first and second passages, fibroblasts in the
culture were collected and stored in liquid nitrogen
for future use.
Mouse embryo genotyping
Each mouse embryo tail was soaked in proteinase K
overnight. Genomic DNA was then extracted using
a DNeasy kit (Qiagen). The extracted DNA was
analyzed by the genomic polymerase chain reaction
(PCR) method using PCR mixtures for genomic
PCR composed of 10X Extaq buffer, 2.5 mM
dNTP, deionized water, Extaq polymerase, and
primers for WT/mutant allele. To detect the mutant
allele, a sense primer, 5?-CTGAAGAAGGAGAT-
CAGCAGCCTC-3?, and an antisense primer, 5?-
GTGTGGGTTCCAGGAATCGTACTGAG-3?,
were used. To detect the WT allele, a sense primer,
5?-ATTAATTCTAGACTGGAACTTAGAGC-3?,
and an antisense primer, 5?-TCTTACAGATCT-
GAATGCCTTACCATCC-3?, were used. Exactly
9 mL of PCR mixture was aliquoted to a PCR tube,
then 1 mL of embryo DNA was added. The PCR
reaction test for WT and mutant alleles was per-
formed. The PCR products were applied to 1%
agarose gel, and electrophoresis was performed.
Visual bands, produced using ethidium bromide,
were used to identify embryo alleles.
[
35S] incorporation assay
Semi-confluent mouse embryonic fibroblasts were
labeled with [
35S]-sulfate (100 mCi/mL) in 100 mm
dishes for 24 hours. The medium and cell layer were
collected separately and extracted using 4 M Guani-
dinium Hydrochloride (GuHCl) as previously de-
scribed (24). Proteoglycans were precipitated with 3
volumes of 95% (v/v) ethanol containing 1.3% (w/v)
potassium acetate. The precipitate was dissolved in
74 K. Suwan et al.buffer A (7 M urea, 50 mM Tris-HCl pH 7.5, 0.01%
Triton X) and then rotated at 48C overnight. The
sample was applied to a DEAE-Sephacel column.
Eluate fractions by 2 M NaCl were collected and
combined. The eluted sample was applied to a gel
filtration (Superose6) column. The proteoglycan
fraction was collected, and its radioactivity was
measured using a Beckman Coulter
TM LS6500
multi-purpose scintillation counter.
Chondroitin sulfate composition analysis
Fibroblasts were cultured in 60 mm culture dishes up
to confluence, after which the medium and cells were
collected. Cell lysate, prepared using Cytobuster
reagent (Novagens), was centrifuged at 13,000 g at
48C for 10 minutes, after which the supernatant was
collected. A sample of supernatant and culture
medium were each applied to a separate 0.3 mL
DEAE-Sephacel column and equilibrated with the
equilibration buffer (50 mM Tris-HCl pH 7.2, 0.1 M
NaCl). After washing with 3 mL of the equilibration
buffer, the proteoglycan fraction was eluted with
elution buffer (50 mM Tris-HCl pH 7.2, 2 M NaCl).
Three volumes of 95% ethanol containing 1.3%
potassium acetate were added to the eluate. The
solution was chilled at  208C overnight and then
centrifuged at 13,000 g for 30 minutes at 48C. The
resulting pellet of proteoglycan was washed twice
with 98% ethanol and then dried. After the pellet was
reconstituted in deionized water, the protein concen-
tration in the precipitated pellet of proteoglycan was
determined by bicinchoninic acid (BCA) assay.
Equal amounts of extracted proteoglycan from WT
and Cspg2
D3/D3 fibroblasts were dissolved in chon-
droitinase ABC buffer (20 mM Tris-HCl pH 8.0, 20
mM sodium acetate, 0.02% bovine serum albumin
(BSA)) and digested with chondroitinase ABC (5
mU/mL) at 378C for 3 hours. The reaction was
stopped by boiling at 1008C for 5 minutes.
The resulting solution was centrifuged at 14,000
rpm for 15 minutes. (Prior to centrifuging the
solution, the centrifuge was prepared by adding
100 mL of distilled water (high performance liquid
chromatography grade) to the centrifugal filter and
centrifuging it twice for 4 minutes each at 14,000
rpm, removing the flow-through each time.) The
flow-through was collected for further analysis by
high performance liquid chromatography (HPLC).
The sample was added to a HPLC vial tube, and
a postcolumn reaction HPLC was performed. The
unsaturated CS disaccharides product was analyzed
by fluorometric postcolumn HPLC, and its content
was calculated from the standard curve of chondroi-
tin sulfate-derived disaccharides.
Protein assay
The bicinchoninic acid (BCA) assay procedure
(Pierce) was used to determine the concentration of
protein in the sample. First, standard albumin was
prepared to establish a calibration curve (2 mg/mL
bovine serum albumin was diluted to get concentra-
tion ranges from 0.5 to 200 mg/mL). Then reagent
A (sodium carbonate, sodium bicarbonate, and
sodium tartrate in 0.2 M sodium hydroxide), reagent
B (4% bicinchoninic acid), and reagent C (4% cupric
sulfate pentahydrate) were thoroughly mixed at the
ratio of 50:48:2, respectively, to make the working
reagent. Each 25 mL of the standard or unknown
sample was placed on a microplate and combined
with 200 mL of the BCA working reagent. The
combination was mixed thoroughly on the plate
shaker for 30 seconds. The plate was then covered
and incubated at 378C for 30 minutes, then cooled
and measured at absorbance 562 nm on the plate
reader. The sample concentration was calculated
from the calibration curve of standard bovine serum
albumin.
Results
Genotyping of mouse embryos
To characterize the genotypes of the mouse embryos,
22 embryos were isolated from heterozygous preg-
nant Cspg2
WT/D3 mice, embryo tails were collected,
and genomic DNA was extracted. The genotype of
each embryo was characterized by using the genomic
PCR technique. Two primer sets were used for
genotype characterization including WT, heterozy-
gous mutant, and homozygous mutant alleles. The
PCR products from the WTallele revealed a band for
the WT primers set (Figure 1). The PCR products
from the homozygous mutant allele revealed a band
for the mutant primers set. The PCR products from
the heterozygous mutant allele revealed bands for
both the WT and mutant primers sets. The results
indicated that embryos number 1, 4, 8, 15, and
21 were WTallele, embryos number6, 12,19, and 22
were homozygous allele, and the remaining embryos
were heterozygous allele. These results were used
for choosing fibroblast culture to perform further
experiments.
We observed that the heterozygous Cspg2
WT/D3
mice were viable, fertile, and without any obvious
abnormalities like WT mice, but the Cspg2
D3/D3
homozygotes died at the embryonic stage. Therefore,
to study the abnormalities of Cspg2
D3/D3 homozygotes,
homozygote alleles (Cspg2
D3/D3 and Cspg2
WT/WT)w e r e
chosen to make fibroblast cultures. The morphology of
WT fibroblasts differed from that of the Cspg2
D3/D3
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D3/D3 fibroblasts appeared larger,
flatter, and more spread out than WT fibroblasts
(Figure 2). In previous experiments, we found that the
proliferation rate of the Cspg2
D3/D3 fibroblasts was
slower than that of the WT fibroblasts, and that the
versican expression level was reduced in the Cspg2
D3/D3
fibroblast cultures. In vitro studies done by Miquel-
Serra et al. (25) on the expression of versican isoform
lacking the chondroitin sulfate chain showed negative
effects on primary cell growth, similar to our results.
Therefore, we suspected that the characteristics of the
chondroitin sulfate on the versican molecules of
Cspg2
D3/D3 fibroblasts might explain some of the
differences shown. For our next experiment, we deter-
mined the chondroitin sulfate composition in versican
extracted from Cspg2
D3/D3 fibroblasts and compared it
with WT versican.
Decrease of chondroitin sulfate proteoglycan deposition in
Cspg2
D3/D3 fibroblasts cultures
To measure the deposition of chondroitin sulfate
proteoglycan in the Cspg2
D3/D3 fibroblast cultures,
semi-confluent fibroblasts were cultured overnight in
the medium containing [
35S]-sulfate because cells
will consume [
35S]-sulfate to be a substrate for
chondroitin sulfate synthesis, and [
35S]-labeled
chondroitin sulfate will be assembled with proteogly-
can core protein. Chondroitin sulfate proteoglycan
was extracted from the culture medium and cell layer
of [
35S]-sulfate-treated fibroblast cultures. The
amounts of proteoglycan deposited in the cell layer
and medium were indicated by the amount of [
35S]
detected by the scintillation counter. Since versican
(23 CS chains bearing chondroitin sulfate proteogly-
can) is a major chondroitin sulfate proteoglycan
expressed in the fibroblast cultures (26), we expected
that the extracted chondroitin sulfate proteoglycan
from mouse embryonic fibroblast cultures in this
experiment would represent as versican. However,
fibroblastsarealsoabletoproducedecorin(27),aCS
chain bearing chondroitin sulfate proteoglycan. To
verify whether the mouse embryonic fibroblasts
cultures in this study produce only versican mole-
cules, Western blot analysis of versican and decorin
molecules was performed by using antibodies against
versican and decorin molecules, respectively. The
results revealed that only versican was detected in the
fibroblast cultures (data not shown). We can con-
clude, therefore, that mouse embryonic fibroblasts in
thestudyproduceonlyversicanaschondroitinsulfate
proteoglycan.
[
35S]-sulfate incorporation studies revealed that
the total versican (culture medium and cell layer)
secreted by Cspg2
D3/D3 fibroblasts was approximately
50% of the total secreted by WT (Figure 3). Of the
total secreted versican of the WT, 70% was deposited
in the cell layer, while only 35% of the total secreted
versican of the Cspg2
D3/D3 was deposited in the cell
layer. This result clearly demonstrated the lower
capacity of mutant (Cspg2
D3/D3) fibroblasts to deposit
versican in the cell layer.
Figure 1. Agarose gel electrophoresis of PCR products from mouse embryo tails. A: wild-type allele determination by genomic PCR; B:
mutant allele determination by genomic PCR. The numbers in ﬁgures A and B represent embryo as follows: number 1 embryo no. 1;
number 2 embryo no. 2; number 3 embryo no. 3; number 4 embryo no. 4; number 5 embryo no. 5; number 6 embryo no. 6;
number 7 embryo no. 7; number 8 embryo no. 8; number 9 embryo no. 9; number 10 embryo no. 10; M 1 kb DNA ladder;
number 11 embryo no. 11; number 12 embryo no. 12; number 13 embryo no. 13; number 14 embryo no. 14; number 15 embryo
no. 15; number 16 embryo no. 16; number 17 embryo no. 17; number 18 embryo no. 18; number 19 embryo no. 19; number 20 
embryo no. 20; number 21 embryo no. 21; number 22 embryo no. 22.
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alters in the Cspg2
D3/D3 fibroblast cultures
To analyze the chondroitin sulfate pattern on
the versican molecule, fibroblasts were cultured until
they reached confluence. Proteoglycan was then
extracted from both the culture medium and cell
layer. Equal amounts of proteoglycan from WT
and mutant fibroblasts were deposited in separate
reaction tubes. The chondroitin sulfate chains on
the versican core protein were digested into dis-
accharide units by chondroitinase ABC. HPLC was
used to determine the chondroitin sulfate content
and composition.
The chondroitin sulfate composition on the
versican core protein was analyzed. The cell layer
of the WT fibroblast cultures contained chondroitin
4-sulfate as the major isomer (87%), while the non-
sulfate chondroitin sulfate was found as the minor
(13%) isomer as shown in Table I. The cell layer of
the Cspg2
D3/D3 fibroblasts culture consisted of 81%
chondroitin 4-sulfate and 19% non-sulfate chondroi-
tin sulfate. Likewise, the culture medium of WT
fibroblasts contained chondroitin 4-sulfate as the
Figure 2. Representative photographs (4  magniﬁcation) showing the cell morphology of wild-type (WT) ﬁbroblasts (A) and Cspg2
D3/D3
ﬁbroblasts (B) at passage no. 4.
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tin sulfate (33%) and chondroitin 6-sulfate (8%)
were the minor isomers. The culture medium
of Cspg2
D3/D3 fibroblasts contained chondroitin 4-
sulfate (59%), non-sulfate chondroitin sulfate
(28%), and chondroitin 6-sulfate (12%). Remark-
ably, a trace amount (1%) of chondroitin sulfate
E was also found. Thus, our results showed that
the percentage of the chondroitin 4-sulfate isomer in
the culture medium of Cspg2
D3/D3 fibroblasts was
the same as that in the culture medium of WT
fibroblasts, but the percentage of the non-sulfate
chondroitin sulfate tended to be lower than that of
the culture medium of WT fibroblasts. We also found
that the negative charge of the chondroitin sulfate
isomers in the culture medium of Cspg2
D3/D3 fibro-
blasts appeared to be higher than that of the culture
medium of WT fibroblasts.
We found that the cell layer of the WT fibroblasts
culture contained 14.1 ng/mL of chondroitin sulfate
from the versican molecule, while the cell layer of the
Cspg2
D3/D3 fibroblast cultures contained 5.0 ng/mLo f
chondroitin sulfate,nearly three times less (Figure 4).
The WT fibroblast culture medium contained 12.1
ng/mL of chondroitin sulfate on the versican mole-
cule, while the Cspg2
D3/D3 fibroblast culture medium
contained 19.0 ng/mL, one-and-a-half times more
(Figure 4). These data showed that the amount of
chondroitin sulfate on the mutant versican molecule
inthecelllayerwasdramaticallylower thanthatinthe
WT cell layer, while the amount in the culture
medium was higher than in the WT medium.
We also found that the cell layer of the WT
fibroblasts culture contained 12.3 ng/mL of chon-
droitin 4-sulfate on the versican molecule, while the
cell layer of the Cspg2
D3/D3 fibroblast cultures con-
tained 4.0 ng/mL, three times less. This demonstrates
that versican molecules in Cspg2
D3/D3 fibroblast
cultures contain less negatively charged chondroitin
sulfate in the extracellular matrix. Interestingly, the
negatively charged chondroitin sulfate increased in
the Cspg2
D3/D3 fibroblast culture medium. We con-
cluded that the disruption of the A subdomain of the
versican molecule leads to the alteration of the
composition and content of chondroitin sulfate on
the versican molecule.
Discussion
In this study we compared certain characteristics of
fibroblasts from Cspg2
D3/D3 mouse embryos with
those of WT mouse embryos, which were studied
Figure 3. Versican deposition in WT and Cspg2
D3/D3 ﬁbroblast
cultures. The deposition of versican molecules was detected by the
[
35S] incorporation assay; the amount of versican deposition was
represented as the intensity of [
35S] isotope (cpm 10
6). The
closed bar (CL) represents the amount of versican deposited in
cell layer, and the open bar (M) represents the amount of versican
deposited in the culture medium. Data are the mean value9
standard deviation of three independent experiments. WT 
wild-type ﬁbroblasts; Cspg2
D3/D3 Cspg2
D3/D3 (mutant) ﬁbro-
blasts.
Table I. Chondroitin sulfate composition in cell layer and ﬁbroblast culture medium; data shown are the percent content of chondroitin
sulfate. Data are the mean values of three independent experiments9standard deviation.
% Chondroitin sulfate content
Cell layer Medium
Wild type Cspg2 Wild type Cspg2
Ddi0S 1390.11 1990.79 3390.50 2890.30
Ddi4S 8790.11 8190.11 5990.55 5990.22
Ddi6S ND ND 890.05 1290.33
DdiSE ND ND ND 190.09
DdiSD ND ND ND ND
Dd i T r i SN DN DN DN D
Ddi0S: non-sulfate chonodroitin sulfate, Ddi4S: chondroitin 4-sulfate, Ddi6S: chondroitin 6-sulfate, DdiSE: chondroitin 4,6-sulfate, DdiSD:
chondroitin 2,6-sulfate, DdiTris: chondroitin 2,4,6-sulfate.
78 K. Suwan et al.earlier. The mutant cells had a slower growth rate
and appeared larger and more spread out than cells
from WT fibroblasts. Yang et al. (28) reported that
the presence of the G1 domain inhibits chondroitin
sulfate chain attachment to versican core protein.
Since the A subdomain is part of the G1 domain, we
suspected that chondroitin sulfate composition and
content on the versican core protein would be
changed if the A subdomain was disrupted. We
investigated this hypothesis by using the Cspg2
D3/D3
fibroblasts as a model. It was found that versican
deposition in the Cspg2
D3/D3 fibroblast cultures was
approximately 50% less than the versican deposition
in the WT fibroblast cultures. A recent study of
versican mRNA in our laboratory showed a decrease
in versican expression in the Cspg2
D3/D3 fibroblast
cultures (unpublished observations). Those results
suggested that loss of the A subdomain affected the
expression of proteoglycan in mutant fibroblasts.
The experiment discussed in this study found that
the versican deposition in the ECM of Cspg2
D3/D3
fibroblasts culture was approximately 35% of that in
the ECM of WT fibroblasts culture, while the
deposition of versican in the medium of Cspg2
D3/D3
fibroblast cultures tended to be higher than in the
culture medium of WT fibroblasts. Matsumoto et al.
showed that versican binds hyaluronan at the B-B?
stretch of the G1 domain and that the A subdomain
enhances their interaction up to 17-fold (1).
Our analysis of chondroitin sulfate was as we
suspected. When the A subdomain was disrupted,
chondroitin sulfate composition on the versican core
protein was changed. Non-sulfate chondroitin
sulfate isomer tended to increase in the cell layer
but to decrease in the culture medium. This
demonstrated that the negative charge on versican
molecules decreased in the ECM but increased in
the culture medium. Interestingly we found chon-
droitin sulfate E (di-sulfated chondroitin sulfate) on
the versican molecule in the culture medium. The
chondroitin sulfate chain has a negative charge
which makes it possible for proteoglycans to bind
various positively charged molecules such as growth
factors, cytokines, and chemokines (29). Moreover it
allows proteoglycans in the ECM or on the cell
surface to generate immobilized gradients of certain
growth factors and present them to their receptors;
chondroitin sulfate chains also protect proteoglycans
from proteolytic degradation (30). We found that
both the charge and the content of chondroitin
sulfate on the versican molecule were decreased
in the cell layer of the Cspg2
D3/D3 fibroblast cultures.
Other studies have shown that the charge of chon-
droitin sulfate regulates cell activity. For example,
the number of neurites decreased with high di-
sulfation chondroitin sulfate (31), and chondroitin
sulfate tetrasaccharide stimulated the growth and
differentiation of neurons (32).
Fluctuation in chondroitin sulfate content has
been found to affect biological activity. An increase in
chondroitin sulfate chains in cephalic neural crest
migratory routes not only disrupts their migration,
but also impedes detachment of the rhombencepha-
lic neuroepithelium neural crest cells (33). Evidence
suggests, then, that the decrease of the total charge
and deposition of versican molecules in the
Cspg2
D3/D3 fibroblasts cell layer will affect the pro-
liferation and morphology of fibroblasts. We can
conclude, then, that the Cspg2
D3/D3 mutant versican
molecule, which contains alower negativecharge and
less chondroitin sulfate on its core protein than
normal versican, does not maintain growth factors
and provides other essential molecules to serve
Figure 4. Chondroitin sulfate content on versican core protein
which deposited in cell layer (upper graph) and culture medium
(lower graph) of ﬁbroblasts using high performance liquid
chromatography (HPLC) analysis. Data are the mean values of
three independent experiments9standard deviation. Each bar
represents the chondroitin sulfate isomer.
Alteration of chondroitin sulfate composition in versican 79cells, and thus leads to the alteration of cell behavior,
such as a slow growth rate and the acquisition of
senescence in the Cspg2
D3/D3 fibroblasts.
In addition, Matsumoto et al. (34) showed that
the chondroitin sulfate composition on the versican
molecule of WT mouse embryo fibroblasts differed
from the composition in mouse cartilage. They
found more non-sulfated chondroitin sulfate than
chondroitin 4-sulfate in mouse cartilage, but more
chondroitin 4-sulfate than non-sulfated chondroitin
in mouse fibroblasts. This is more evidence that,
even though versican is distributed throughout the
body, the composition of chondroitin sulfate on the
versican molecule is different for different tissues.
Declaration of interest: The authors report no
conflicts of interest. The authors alone are respon-
sible for the content and writing of the paper.
References
1. Matsumoto K, Shionyu M, Go M, Shimizu K, Shinomura T,
Kimata K, et al. Distinct interaction of versican/PG-M with
hyaluronan and link protein. J Biol Chem. 2003;278:
41205 12.
2. Isogai Z, Aspberg A, Keene DR, Ono RN, Reinhardt DP,
Sakai LY. Versican interacts with ﬁbrillin-1 and links
extracellular microﬁbrils to other connective tissue networks.
J Biol Chem. 2002;277:4565 72.
3. Aspberg A, Adam S, Kostka G, Timpl R, Heinega ˚rd D.
Fibulin-1 is a ligand for the C-type lectin domains of
aggrecan and versican. J Biol Chem. 1999;274:20444 9.
4. Olin AI, Morgelin M, Sasaki T, Timpl R, Heinega ˚rd D,
Aspberg A. The proteoglycans aggrecan and versican form
networks with ﬁbulin-2 through their lectin domain binding.
J Biol Chem. 2001;276:1253 61.
5. Aspberg A, Binkert C, Ruoslahti E. The versican C-type
lectin domain recognizes the adhesion protein tenascin-R.
Proc Natl Acad Sci U S A. 1995;92:10590 4.
6. Suwiwat S, Ricciardelli C, Tammi R, Tammi M, Auvinen P,
Kosma VM, et al. Expression of extracellular matrix compo-
nents versican, chondroitin sulfate, tenascin, and hyaluronan,
and their association with disease outcome in node-negative
breast cancer. Clin Cancer Res. 2004;10:2491 8.
7. Tsujii M, Hirata H, Yoshida T, Imanaka-Yoshida K, Morita
A, Uchida A. Involvement of tenascin-C and PG-M/versican
in ﬂexor tenosynovial pathology of idiopathic carpal tunnel
syndrome. Histol Histopathol. 2006;21:511 8.
8. Yamagata M, Yamada KM, Yoneda M, Suzuki S, Kimata K.
Chondroitin sulfate proteoglycan (PG-M-like proteoglycan)
is involved in the binding of hyaluronic acid to cellular
ﬁbronectin. J Biol Chem. 1986;261:13526 35.
9. Yamagata M, Kimata K. Repression of a malignant cell-
substratum adhesion phenotype by inhibiting the production
of the anti-adhesive proteoglycan, PG-M/versican. J Cell Sci.
1994;107:2581 90.
10. Braunewell KH, Pesheva P, McCarthy JB, Furcht LT,
Schmitz B, Schachner M. Functional involvement of sciatic
nerve-derived versican- and decorin-like molecules and
other chondroitin sulphate proteoglycans in ECM-mediated
cell adhesion and neurite outgrowth. Eur J Neurosci.
1995;7:805 14.
11. Mazzucato M, Cozzi MR, Pradella P, Perissinotto D,
Malmstrom A, Morgelin M, et al. Vascular PG-M/versican
variants promote platelet adhesion at low shear rates and
cooperate with collagens to induce aggregation. FASEB J.
2002;16:1903 16.
12. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann
DR. Versican is selectively expressed in embryonic tissues
that act as barriers to neural crest cell migration and axon
outgrowth. Development. 1995;121:2303 12.
13. Evanko SP, Angello JC, Wight TN. Formation of hyalur-
onan- and versican-rich pericellular matrix is required for
proliferation and migration of vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol. 1999;19:1004 13.
14. Perissinotto D, Iacopetti P, Bellina I, Doliana R, Colombatti
A, Pettway Z, et al. Avian neural crest cell migration is
diversely regulated by the two major hyaluronan-binding
proteoglycans PG-M/versican and aggrecan. Development.
2000;127:2823 42.
15. Cattaruzza S, Schiappacassi M, Kimata K, Colombatti A,
Perris R. The globular domains of PG-M/versican modulate
the proliferation-apoptosis equilibrium and invasive capabil-
ities of tumor cells. FASEB J. 2004;18:779 81.
16. Hinek A, Braun KR, Liu K, Wang Y, Wight TN. Retrovirally
mediated overexpression of versican v3 reverses impaired
elastogenesis and heightened proliferation exhibited by ﬁbro-
blasts from Costello syndrome and Hurler disease patients.
Am J Pathol. 2004;164:119 31.
17. Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PS, et al.
The roles of versican V1 and V2 isoforms in cell proliferation
and apoptosis. Mol Biol Cell. 2005;16:1330 40.
18. Domenzain C, Docampo MJ, Serra M, Miquel L, Bassols A.
Differential expression of versican isoforms is a component of
the human melanoma cell differentiation process. Biochim
Biophys Acta. 2003;1642:107 14.
19. Wu Y, Sheng W, Chen L, Dong H, Lee V, Lu F, et al.
Versican V1 isoform induces neuronal differentiation and
promotes neurite outgrowth. Mol Biol Cell. 2004;15:
2093 104.
20. Zhang Y, Cao L, Yang BL, Yang BB. The G3 domain of
versican enhances cell proliferation via epidermial growth
factor-like motifs. J Biol Chem. 1998;273:21342 51.
21. Wu Y, Chen L, Zheng PS, Yang BB. beta 1-Integrin-
mediated glioma cell adhesion and free radical-induced
apoptosis are regulated by binding to a C-terminal domain
of PG-M/versican. J Biol Chem. 2002;277:12294 301.
22. Serrano M, Lin AW, MacCurrach ME, Beach D, Lowe SW.
Oncogenic ras provokes premature cell senescence asso-
ciated with accumulation of p53 and p16INK4a. Cell.
1997;88:593 602.
23. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D,
Markwald RR. The Cspg2 gene, disrupted in the hdf mutant,
is required for right cardiac chamber and endocardial cushion
formation. Dev Biol. 1998;202:56 66.
24. Kimata K, Oike Y, Tani K, Shinomura T, Yamagata M,
Uritani M, et al. A large chondroitin sulfate proteoglycan
(PG-M) synthesized before chondrogenesis in the limb bud
of chick embryo. J Biol Chem. 1986;261:13517 25.
25. Miquel-Serra L, Serra M, Hernandez D, Domenzain C,
Docampo MJ, Rabanal RM, et al. V3 versican isoform
expression has a dual role in human melanoma tumor growth
and metastasis. Lab Invest. 2006;86:889 901.
26. Zimmermann DR, Ruoslahti E. Multiple domains of
the large ﬁbroblast proteoglycan, versican. EMBO J.
1989;8:2975 81.
27. Scott PG, Dodd CM, Ghahary A, Shen YJ, Tredget EE.
Fibroblasts from post-burn hypertrophic scar tissue synthe-
80 K. Suwan et al.size less decorin than normal dermal ﬁbroblasts. Clin Sci
(Lond). 1998;94:541 7.
28. Yang BL, Cao L, Kiani C, Lee V, Zhang Y, Adams ME, et al.
Tandem repeats are involved in G1 domain inhibition of
versican expression and secretion and the G3 domain
enhances glycosaminoglycan modiﬁcation and product secre-
tion via the complement-binding protein-like motif. J Biol
Chem. 2000;275:21255 61.
29. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE,
Pinchasi D, Huang J, et al. Heparin-induced oligomerization
of FGF molecules is responsible for FGF receptor dimeriza-
tion, activation, and cell proliferation. Cell. 1994;79:
1015 24.
30. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell
surface, heparin-like molecules are required for binding of
basic ﬁbroblast growth factor to its high afﬁnity receptor.
Cell. 1991;64:841 8.
31. Rapp A, Brandl N, Volpi N, Huettinger M. Evaluation of
chondroitin sulfate bioactivity in hippocampal neurones and
the astrocyte cell line U373: inﬂuence of position of sulfate
groups and charge density. Basic Clin Pharmacol Toxicol.
2005;96:37 43.
32. Tully SE, Mabon R, Gama CI, Tsai SM, Liu X,
Hsieh-Wilson LC. A chondroitin sulfate small molecule
that stimulates neuronal growth. J Am Chem Soc. 2004;
126:7736 7.
33. Moro BJA, Gato A, Alonso A, Barbosa E. Local increase level
of chondroitin sulfate induces changes in the rhombence-
phalic neural crest migration. Int J Dev Biol. 1998;42:
207 16.
34. Matsumoto K, Kamiya N, Suwan K, Atsumi F, Shimizu K,
Shinomura T, et al. Identiﬁcation and characterization of
versican/PG-M aggregates in cartilage. J Biol Chem. 2006;
281:18257 63.
Alteration of chondroitin sulfate composition in versican 81